XML 18 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2024   250.0        
Beginning balance at Dec. 31, 2024 $ 20,180.0 $ 250.0 $ 16,069.0 $ 4,986.0 $ (1,151.0) $ 26.0
Net earnings 709.0     704.0   5.0
Net purchase of subsidiary shares from noncontrolling interests 3.0         3.0
Foreign currency translation 217.0       217.0  
Compensation expense related to stock option plan grants 18.0   18.0      
Common stock issued in:            
Purchase transactions (in shares)   0.1        
Purchase transaction 17.0 $ 0.1 17.0      
Stock option plans (in shares)   0.7        
Stock option plans 69.0 $ 0.7 68.0      
Employee stock purchase plan (in shares)   0.1        
Employee stock purchase plan 14.0 $ 0.1 14.0      
Stock issuance from public offering (in shares)   4.6        
Stock issuance from public offering 1,252.0 $ 4.6 1,248.0      
Shares issued to benefit plans (in shares)   0.3        
Shares issued to benefit plans 120.0 $ 0.3 119.0      
Deferred compensation and restricted stock (in shares)   0.3        
Deferred compensation and restricted stock (77.0) $ 0.3 (77.0)      
Cash dividends declared on common stock (167.0)     (167.0)    
Ending balance, (in shares) at Mar. 31, 2025   256.1        
Ending balance at Mar. 31, 2025 $ 22,354.0 $ 256.1 17,475.0 5,523.0 (934.0) 34.0
Beginning balance (in shares) at Dec. 31, 2025 257.0 257.0        
Beginning balance at Dec. 31, 2025 $ 23,347.0 $ 257.0 17,783.0 5,806.0 (525.0) 26.0
Net earnings 823.0     822.0   1.0
Foreign currency translation (20.0)       (20.0)  
Change in fair value of derivative instruments, net of taxes (21.0)       (21.0)  
Compensation expense related to stock option plan grants 20.0   20.0      
Common stock issued in:            
Purchase transactions (in shares)   0.1        
Purchase transaction $ 17.0 $ 0.1 17.0      
Stock option plans (in shares) 0.5 0.4        
Stock option plans $ 36.0 $ 0.4 36.0      
Employee stock purchase plan (in shares)   0.1        
Employee stock purchase plan 15.0 $ 0.1 15.0      
Shares issued to benefit plans (in shares)   0.5        
Shares issued to benefit plans 132.0 $ 0.5 131.0      
Deferred compensation and restricted stock (in shares)   0.2        
Deferred compensation and restricted stock (55.0) $ 0.2 (55.0)      
Common stock repurchases (in shares)   (1.4)        
Common stock repurchases (310.0) $ (1.4) (309.0)      
Cash dividends declared on common stock $ (182.0)     (182.0)    
Ending balance, (in shares) at Mar. 31, 2026 256.9 256.9        
Ending balance at Mar. 31, 2026 $ 23,802.0 $ 256.9 $ 17,638.0 $ 6,446.0 $ (566.0) $ 27.0